Trial site
Univerzitetni klinični center Maribor
- 12running trials
- 15closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis5 trials
- Alzheimer disease3 trials
- Sjögren's disease3 trials
- Atopic dermatitis (eczema)2 trials
- Endometrial cancer2 trials
- Epilepsy2 trials
- IgA nephropathy2 trials
- Mild cognitive impairment2 trials
- Ulcerative colitis2 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Heart failure1 trial
- Hidradenitis suppurativa1 trial
- and 4 more
- Phase
- Phase 322 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Completed15 trials
- Active, not recruiting6 trials
- Recruiting6 trials
- Suspended1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Amgen3 trials
- Novartis Pharmaceuticals3 trials
- Amgen Inc.2 trials
- Biohaven Therapeutics Ltd.2 trials
- and 14 more
Running trials
Recruiting
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Endometrial cancer1 recruiting
- Epilepsy1 recruiting
- IgA nephropathy1 recruiting
- Multiple myeloma1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Effects of ABX464 during long-term treatment in patients with moderate to severe ulcerative colitis
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026